Earnings
AbbVie shares slide as Humira barely beats sales estimates
AbbVie barely beat Wall Street forecasts on sales of its mainstay medicine Humira, failing to allay investors’ concerns over the future of the cash cow product and sending the drugmaker’s shares down 5 percent on […]